Alaunos Therapeutics Company
Alaunos Therapeutics is a biotechnology company that acquires, develops, and commercializes cancer therapies.
Technology:
Cell-based gene therapy
Industry:
Public
Headquarters:
New York, New York, United States
Founded Date:
2005-01-01
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
9
Total Funding:
293392527
Estimated Revenue:
Less than $1M
Last Funding Date:
2022-11-29
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership